Pathophysiological role of calcium channels and transporters in the multiple myeloma

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Multiple myeloma (MM) is an aggressive plasma cell malignancy with poor prognosis despite recent advances.
• Myeloma bone disease (MBD), a common complication, leads to fractures and hypercalcemia, worsening patient outcomes.
• Calcium homeostasis, regulated by channels and transporters, is implicated in MM pathogenesis and progression.

Purpose of the Study:

• To review the critical roles of calcium channels and transporters in multiple myeloma prognosis.
• To elucidate the involvement of calcium signaling in myeloma bone disease.
• To identify potential new therapeutic targets for MM based on calcium regulation.

Main Methods:

• Literature review of studies on calcium channels, transporters, and multiple myeloma.
• Analysis of the function of calcium channels and transporters in plasma cells, bone microenvironment, and mitochondria.
• Synthesis of current knowledge on calcium dysregulation in MM and MBD.

Main Results:

• Specific calcium channels and transporters are dysregulated in MM, affecting plasma cell survival and bone remodeling.
• Calcium signaling pathways are crucial for the development and progression of myeloma bone disease.
• Mitochondrial calcium handling appears to play a significant role in MM cell viability.

Conclusions:

• Targeting calcium channels and transporters presents a promising strategy for MM treatment.
• Modulating calcium homeostasis may alleviate myeloma bone disease and improve patient prognosis.
• Further research into calcium signaling in MM could uncover novel therapeutic avenues.